Mitochondrial DNA and human thyroid diseases

Area of Science:

• Mitochondrial genetics
• Thyroid pathology
• Cancer genomics

Background:

• Mitochondrial genomes can accumulate alterations in thyroid cells, affecting both normal and diseased tissues.
• Various types of mitochondrial DNA (mtDNA) aberrations, including point mutations and deletions, have been observed in different thyroid conditions.

Purpose of the Study:

• To investigate the occurrence and distribution of mtDNA mutations and large-scale deletions in thyroid lesions.
• To explore the correlation between mtDNA alterations and pathological characteristics of thyroid tumors.

Main Methods:

• Analysis of mitochondrial genomes in thyroid tissues (primary lesions and surrounding parenchyma).
• Detection of homoplasmic/heteroplasmic point mutations, common deletions, and large-scale mtDNA aberrations.
• Comparison of mtDNA alterations between cancerous and control thyroid tissues.

Main Results:

• Point somatic mutations are present in 5-60% of thyroid tumors, clustering in specific mtDNA regions.
• Large-scale mtDNA deletions are prevalent in both healthy and diseased thyroids, but represent a small fraction of total mtDNA.
• The common deletion is frequent in Hurthle cell tumors and also found in other thyroid conditions and normal tissue.
• Elevated relative mtDNA levels are observed in most thyroid tumors compared to normal tissue.

Conclusions:

• The differential distribution and prevalence of mtDNA mutations in thyroid lesions suggest their involvement in thyroid diseases, especially thyroid cancer.
• While large-scale deletions are common, their proportion is small and doesn't consistently correlate with tumor pathology.
• mtDNA alterations may play a significant role in the pathogenesis of thyroid diseases.